Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol - Jazayeri-Tehrani, S. A.; Rezayat, S. M.; Mansouri, S.; Qorbani, M.; Alavian, S. M.; Daneshi-Maskooni, M.; Hosseinzadeh-Attar, M. J. (BMJ Open, 2017)

The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (nafld): a double-blind randomized placebo-controlled clinical trial - Jazayeri-Tehrani, S. A.; Rezayat, S. M.; Mansouri, S.; Qorbani, M.; Alavian, S. M.; Daneshi-Maskooni, M.; Hosseinzadeh-Attar, M. J. (Nanomedicine Journal, 2018)

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial - Daneshi-Maskooni, M.; Keshavarz, S. A.; Qorbani, M.; Mansouri, S.; Alavian, S. M.; Badri-Fariman, M.; Jazayeri-Tehrani, S. A.; Sotoudeh, G. (Nutrition & metabolism, 2018)

The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial - Daneshi-Maskooni, M.; Keshavarz, S. A.; Mansouri, S.; Qorbani, M.; Alavian, S. M.; Badri-Fariman, M.; Jazayeri-Tehrani, S. A.; Sotoudeh, G. (Trials, 2017)

Nesfatin-1 and its effects on different systems - Ayada, C.; Toru, Ü.; Korkut, Y. (Hippokratia, 2015)

A novel appetite peptide, nesfatin-1 in patients with the non-alcoholic fatty liver disease - Başar, O.; Akbal, E.; Köklü, S. (Scand J Clin Lab Invest, 2012)

Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss - Dixon, J. B.; Bhathal, P. S.; Hughes, N. R.; O’Brien, P. E. (Hepatology, 2004)

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty - Luyckx, F. H.; Desaive, C.; Thiry, A.; Dewe, W.; Scheen, A. J.; Gielen, J. E.; Lefebvre, P. J. (Int J Obes Relat Metab Disord, 1998)

Effect of greater cardamom (Amomum subulatum Roxb.) on blood lipids, fibrinolysis and total antioxidant status in patients with ischemic heart disease - Verma, S. K.; Jain, V.; Singh, D. P. (Asian Pacific J Trop Dis, 2012)

Effect of weight reduction on hepatic abnormalities in overweight patients - Palmer, M.; Schaffner, F. (Gastroenterology, 1990)

The lab tests online. Laboratory methods used for medical lab testing (enzyme-linked immunosorbent assay (ELISA)) [Internet]. 2012. [cited 26 Feb 2017]. Available from: https://labtestsonline.org/understanding/features/methods/start/2/. Accessed 26 Feb 2017.

Food and nutrient intake status in urban population (20–60 years) of population research center of Tehran University of Medical Sciences - Jazayeri, S.; Nouri, M.; Pour-Ebrahim, R.; Fakhrzadeh, H.; Larijani, B. (Iran J Diab Lipid, 2005)

Guides of home scales, conversion coefficients and percentage of Iranian foods - Qaffarpour, M.; Houshyar-Rad, A.; Kianfar, H. (Agricultural Sciences Publication, 2000)

The IPAQ group. International Physical Activity Questionnaire [Internet]. 2017. [cited 26 Feb 2017]. Available from: https://sites.google.com/site/theipaq/.

International physical activity questionnaire: 12-country reliability and validity - Booth, M. L.; Ainsworth, B. E.; Pratt, M. I.; Ekelund, U.; Yngve, A. G.; Sallis, J. F.; Oja, P. E. (Med Sci Sports Exerc, 2003)

Curcumin extract for prevention of type 2 diabetes - Chuengsamarn, S.; Rattanamongkolgul, S.; Luechapudiporn, R. (Diabetes Care, 2012)

Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial - Panahi, Y.; Kianpour, P.; Mohtashami, R.; Jafari, R.; Simental-Mendía, L. E.; Sahebkar, A. (Drug research, 2017)

Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial - Chuengsamarn, S.; Rattanamongkolgul, S.; Phonrat, B.; Tungtrongchitr, R.; Jirawatnotai, S. (J Nutr Biochem, 2014)

Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial - Panahi, Y.; Khalili, N.; Sahebi, E.; Namazi, S.; Karimian, M. S.; Majeed, M.; Sahebkar, A. (Inflammopharmacology, 2017)

Curcumin: a review of its’ effects on human health - Hewlings, S. J.; Kalman, D. S. (Foods, 2017)

Oxidative stress and endoplasmic reticulum stress as potential therapeutic targets in non-alcoholic fatty liver disease - Lizana, P.; Galdames, M.; Rodrigo, R. (Reactive Oxygen Species, 2017)

Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases - Navekar, R.; Rafraf, M.; Ghaffari, A.; Asghari-Jafarabadi, M.; Khoshbaten, M. (J Am Coll Nutr, 2017)

Curcumin, an active component of turmeric (Curcuma longa), and its effects on health - Kocaadam, B.; Şanlier, N. (Crit Rev Food Sci Nutr, 2017)

Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity - Jin, T.; Song, Z.; Weng, J.; Fantus, I. G. (American Journal of Physiology-Endocrinology and Metabolism, 2018)

Effect of curcumin on anthropometric measures: a systematic review on randomized clinical trials - Hariri, M.; Haghighatdoost, F. (J Am Coll Nutr, 2018)

Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome - Shen, P.; Han, Y.; Cai, B.; Wang, Y. (Sleep and Breathing, 2015)

Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013.

Syabaniarti AN. The Relationship between Body Mass Index (BMI) and Waist Circumference (WC) to fasting blood glucose level based on the medical check-up result of PT. X Regional Jakarta Employees Year 2016. 2nd International Seminar on Global Health (ISGH); 2018: 306–312. http://repository.stikesayani.ac.id/index.php/isgh2/article/view/66.

Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice - Dong, J.; Xu, H.; Wang, P. F.; Cai, G. J.; Song, H. F.; Wang, C. C.; Dong, Z. T.; Ju, Y. J.; Jiang, Z. Y. (PLoS One, 2013)

Kim SH, Ahn M, Jung IA, Jeon YJ, Cho WK, Cho KS, Park SH, Jung MH, Suh BK. The relation of serum Nesfatin-1 level with anthropometric and metabolic parameters in Korean children and young adolescents. ESPE Abstracts 2015; 84: P2–375. http://abstracts.eurospe.org/hrp/0084/hrp0084p2-375.htm.

The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children - Abaci, A.; Catli, G.; Anik, A.; Kume, T.; Bober, E. (Pediatr Diabetes, 2013)

The correlation between nesfatin-1 and blood pressure in healthy normal weight and obese adults - Hamedani, N. K.; Hosseinzadeh-Attar, M. J.; Hosseini, M. (International Research Journal of Applied and Basic Sciences, 2014)

Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: systematic review and meta-analysis of randomized controlled trials - Meloa, I. S.; Santosb, A. F.; Buenoc, N. B. (Pharmacol Res, 2017)

The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial - Rahimi, H. R.; Mohammadpour, A. H.; Dastani, M.; Jaafari, M. R.; Abnous, K.; Ghayour, M. M.; Kazemi, R. O. (Avicenna journal of phytomedicine, 2016)

Kim HG, Lee SB, Lee JS, Kim WY, Choi SH, Son CG. Artemisia iwayomogi plus Curcuma longa Synergistically Ameliorates Nonalcoholic Steatohepatitis in HepG2 Cells. Evidence-Based Complementary and Alternative Medicine. 2017; Article ID 4390636. 9 pages. Doi: https://doi.org/10.1155/2017/4390636.

Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principal constituent curcumin - Ghorbani, Z.; Hekmatdoost, A.; Mirmiran, P. (International journal of endocrinology and metabolism, 2014)

Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial - Panahi, Y.; Khalili, N.; Sahebi, E.; Namazi, S.; Reiner, Ž.; Majeed, M.; Sahbekar, A. (Complementary therapies in medicine, 2017)

Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial - Mohammadi, A.; Sahebkar, A.; Iranshahi, M.; Amini, M.; Khojasteh, R.; Ghayour-Mobarhan, M.; Ferns, G. A. (Phytother Res, 2013)

Therapeutic roles of curcumin: lessons learned from clinical trials - Gupta, S. C.; Patchva, S.; Aggarwal, B. B. (AAPS J, 2013)

Curcumin and liver cancer: a review - S Darvesh, A.; B Aggarwal, B.; Bishayee, A. (Curr Pharm Biotechnol, 2012)

Ballantyne M. The Pharmacognosy and Therapeutic Efficacy of Turmeric (Curcuma longa): A Systematic Review. Senior Honors Projects. 2017; Paper 573. http://digitalcommons.uri.edu/srhonorsprog/573

Cardiovascular protection by curcumin: molecular aspects - Kapakos, G.; Youreva, V.; Srivastava, A. K. (Indian J Biochem Biophys, 2012)

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects - Lopresti, A. L.; Hood, S. D.; Drummond, P. D. (J Psychopharmacol, 2012)

Antioxidant and anti-inflammatory activities of curcumin on diabetes mellitus and its complications - Meng, B.; Li, J.; Cao, H. (Curr Pharm Des, 2013)

Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies - Mirzaei, H.; Shakeri, A.; Rashidi, B.; Jalili, A.; Banikazemi, Z.; Sahebkar, A. (Biomed Pharmacother, 2017)

A review of the therapeutic effects of curcumin - Noorafshan, A.; Ashkani-Esfahani, S. (Curr Pharm Des, 2013)

Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis of randomized controlled trials - Sahebkar, A.; Cicero, A. F.; Simental-Mendía, L. E.; Aggarwal, B. B.; Gupta, S. C. (Pharmacol Res, 2016)

Molecular mechanisms of curcumin action: signal transduction - Shehzad, A.; Lee, Y. S. (Biofactors, 2013)

Relations of visceral and abdominal subcutaneous adipose tissue, body mass index, and waist circumference to serum concentrations of parameters of chronic inflammation - Schlecht, I.; Fischer, B.; Behrens, G.; Leitzmann, M. F. (Obesity facts, 2016)

Does one size fit all? The role of body mass index and waist circumference in systemic inflammation in midlife by race and gender - Stepanikova, I.; Oates, G. R.; Bateman, L. B. (Ethnicity & health, 2017)

Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms - Panahi, Y.; Ahmadi, Y.; Teymouri, M.; Johnston, T. P.; Sahebkar, A. (J Cell Physiol, 2018)

Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials - Qin, S.; Huang, L.; Gong, J.; Shen, S.; Huang, J.; Ren, H.; Hu, H. (Nutr J, 2017)

A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels - Sahebkar, A. (Clin Nutr, 2014)

Central nesfatin-1 influences the excitability of ghrelin-responsive gastric distension neurons in the arcuate nucleus and reduces gastric motility in rats - Li, Z. L.; Xu, L.; Sun, X. R.; Guo, F. F.; Gong, Y. L.; Gao, S. L. (Eur J Neurosci, 2013)

Veghari G, Sedaghat M, Joshaghani H, Banihashem S, Moharloei P, Angizeh A, Tazik E, Moghaddami A, Hajian-Tilaki K, ZahedPasha Y. The association of fasting blood glucose (FBG) and waist circumference in northern adults in Iran: a population-based study. Journal of Diabetes & Metabolic Disorders 2014 Dec;13(1):2. http://www.jdmdonline.com/content/13/1/2

Metabolic and cardiovascular actions of nesfatin-1: implications in health and disease - Ramesh, N.; Gawli, K.; Kiran Pasupulleti, V.; Unniappan, S. (Curr Pharm Des, 2017)

AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1 - Yin, Y.; Li, Z.; Gao, L.; Li, Y.; Zhao, J.; Zhang, W. (Mol Cell Endocrinol, 2015)

Regulatory neuropeptides (ghrelin, obestatin, and nesfatin-1) levels in serum and reproductive tissues of female and male rats with the fructose-induced metabolic syndrome - Catak, Z.; Aydin, S.; Sahin, İ.; Kuloglu, T.; Aksoy, A.; Dagli, A. F. (Neuropeptides, 2014)

Lipid profile, waist circumference, and body mass index in a high altitude population - Mohanna, S.; Baracco, R.; Seclén, S. (High Alt Med Biol, 2006)

The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population - Kang, H. T.; Yoon, J. H.; Kim, J. Y.; Ahn, S. K.; Linton, J. A.; Koh, S. B.; Kim, J. K. (Nutr Metab Cardiovasc Dis, 2012)

Hepatoprotective and immunomodulatory properties of aqueous extract of Curcuma longa in carbon tetrachloride intoxicated Swiss albino mice - Sengupta, M.; Sharma, G. D.; Chakraborty, B. (Asian Pacific journal of tropical biomedicine, 2011)

Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research - Jurenka, J. S. (Altern Med Rev, 2009)

Curcumin: an effective inhibitor of interleukin-6 - Ghandadi, M.; Sahebkar, A. (Curr Pharm Des, 2017)

Curcumin: from ancient medicine to current clinical trials - Hatcher, H.; Planalp, R.; Cho, J.; Torti, F. M.; Torti, S. V. (Cell Mol Life Sci, 2008)

Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials - Derosa, G.; Maffioli, P.; Simental-Mendía, L. E.; Bo, S.; Sahebkar, A. (Pharmacol Res, 2016)

Jacob A, Wu R, Zhou M, Wang P. Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-γ Activation. PPAR Research 2007; Article ID: 89369. 5 pages. doi:https://doi.org/10.1155/2007/89369.

The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain - Tang, C. H.; Fu, X. J.; Xu, X. L.; Wei, X. J.; Pan, H. S. (Peptides, 2012)

Nesfatin-1 alleviates gastric damage via direct antioxidant mechanisms - Kolgazi, M.; Cantali-Ozturk, C.; Deniz, R.; Ozdemir-Kumral, Z. N.; Yuksel, M.; Sirvanci, S.; Yeğen, B. C. (journal of surgical research, 2015)

Effects of endurance training and herb supplementation on tissue nesfatin-1/nucleobindin-2 and ghrelin mRNA expression - Shirvani, H.; Ghanbari-Niaki, A.; Rahmati-Ahmadabad, S. (International Journal of Applied Exercise Physiology, 2017)

Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation - Afrin, R.; Arumugam, S.; Rahman, A.; Wahed, M. I.; Karuppagounder, V.; Harima, M.; Suzuki, H.; Miyashita, S.; Suzuki, K.; Yoneyama, H.; Ueno, K. (Int Immunopharmacol, 2017)

Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving heme oxygenase-1 induction - Bao, W.; Li, K.; Rong, S.; Yao, P.; Hao, L.; Ying, C.; Zhang, X.; Nussler, A.; Liu, L. (J Ethnopharmacol, 2010)

The protective effects of (1E, 6E)-1, 7-diphenylhepta-1, 6-diene-3, 5-dione, a curcumin analogue, against operative liver injury in rats - Chi, X.; Yu, D.; Li, P.; Lu, Q.; Jiang, W.; Hao, K. (Eur J Pharm Sci, 2017)

Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis - Guo, C.; Ma, J.; Zhong, Q.; Zhao, M.; Hu, T.; Chen, T.; Qiu, L.; Wen, L. (Toxicol Appl Pharmacol, 2017)